Introduction
The term lipocortin (LC) indicates the members of a family of calcium-and phospholipid-binding proteins, also called annexins, whose physiological role remains to be fully clarified. They have been proposed to mediate part of the anti-inflammatory action of glucocorticoid hormones, and to date clear anti-inflammatory activity has been described for three members of this family, LC1, 2 LC23 and LC5. 4 It has been suggested recently that the anti-inflammatory site of human LC1 may be located in region 247-255 which is strictly homologous to portion 39-47 of rabbit uteroglobin, another steroid-inducible anti-PLA2 protein. The nonapeptides corresponding to these high homology regions showed anti-inflammatory activity, and have been named antiflammins (AFs), with AF-1 (Met-Gln-Met-Lys-Lys-Val-Leu-AspSer) being drawn from uteroglobin and AF-2 (His-Asp-Met-Asn-Lys-Val-Leu-Asp- Leu Ser-H is-Leu-Arg-Lys-Val-Phe-Asp-Lys
Leu Arg-Lys-Val-Phe-Asp-Lys Lys-Val-Phe-Asp-Lys Ser-His-Leu-Arg-Lys 1B ) and of 420/zM in the platelet aggregation system (Fig. 2B) . The analogue of LC1 was less 6 The second model used in this study was the ADP induced platelet aggregation which has been reported to be sensitive to both AF-1 and AF-2. 8 
